Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10039946HBVENSG00000142319.19protein_codingSLC6A3NoNo6531Q01959
TVIS10040735HBVENSG00000142319.19protein_codingSLC6A3NoNo6531Q01959
TVIS20001818HPVENSG00000142319.19protein_codingSLC6A3NoNo6531Q01959
TVIS20010059HPVENSG00000142319.19protein_codingSLC6A3NoNo6531Q01959
TVIS44025444HTLV-1ENSG00000142319.19protein_codingSLC6A3NoNo6531Q01959
TVIS44016388HTLV-1ENSG00000142319.19protein_codingSLC6A3NoNo6531Q01959
TCGA Plot Options
Drug Information
GeneSLC6A3
DrugBank IDDB06700
Drug NameDesvenlafaxine
Target IDBE0000647
UniProt IDQ01959
Regulation Typeinhibitor
PubMed IDs20944767
CitationsLiebowitz MR, Tourian KA: Efficacy, safety, and tolerability of Desvenlafaxine 50 mg/d for the treatment of major depressive disorder:a systematic review of clinical trials. Prim Care Companion J Clin Psychiatry. 2010;12(3). pii: PCC.09r00845. doi: 10.4088/PCC.09r00845blu.
GroupsApproved; Investigational
Direct ClassificationCyclohexanols
SMILESCN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1
PathwaysVenlafaxine Metabolism Pathway
PharmGKBPA165958374
ChEMBLCHEMBL1118